3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
14
Lymphoma, Non-Hodgkin
10
Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, B-Cell
5
Lymphoma
5
Solid Tumors
4
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Arthritis, Rheumatoid
4
Ovarian Neoplasms
3
Lymphoma, Follicular
3
Leukemia
3
Hematologic Neoplasms
3
Cytokine Release Syndrome
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Urinary Bladder Neoplasms
2
Respiratory Distress Syndrome
2
Pancreatic Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Mantle-Cell
2
Fallopian Tube Neoplasms
2
Craniopharyngioma
2
Carcinoma, Hepatocellular
2
Interventions
Nutrition Assessment
2
Collagenases
2
upadacitinib
1
tocilizumab
1
acetaminophen, aspirin, caffeine drug combination
1
Vaccines
1
Transcutaneous Electric Nerve Stimulation
1
Saline Solution
1
Resistance Training
1
Radiotherapy
1
Omeprazole
1
Naproxen
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Lysine Acetyltransferase 5
1
Holistic Health
1
Herpes Zoster Vaccine
1
Febuxostat
1
Exergaming
1
Exercise Therapy
1
Colchicine
1
Blood Specimen Collection
1
Allopurinol
1
Adalimumab
1
Abatacept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Arthritis
×
tocilizumab
×
Clear all
NCT03601611
2020-04-21
COLAR
Herlev Hospital
Phase NA
Completed
20 enrolled